← Leaderboards
Lalita A. Shevde
University Of South Alabama
$6,988,503
Attributed
$8,314,141
Total exposure
8
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2011–25$2M$1.5M$1M$500K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,314,141 · 8
By mechanism
R01$4,355,295 · 3
R25$2,651,277 · 2
P30$925,739 · 2
R21$381,830 · 1
Top collaborators
- J Michael Wyss5 shared
- Elizabeth E Brown2 shared
Most similar at University Of South Alabama
Same institution · by research overlap
- Marcel E Conrad$1,961,479
- Jon David Simmons$756,000
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsPathway InteractionsProgramsSignal TransductionBreast Cancer CellNeoplastic CellMalignant Breast NeoplasmTumorCellsCell ProliferationAreaEventCancer BiologyClinical TrialsResearch PersonnelSiteFoundationsNext GenerationPositioning AttributeComprehensive Cancer CenterAlabamaInterestCareerMentors
Grant awards (27)
Cancer Research Training and Education Coordination$457,961
P30 · FY2025 · CA · contact PI
Role of O-GlcNAc-ylation on tumor progression$378,994
R01 · FY2025 · CA · contact PI
Targeting actionable liabilities in Merlin-deficient breast cancer$208,271
R21 · FY2025 · CA · contact PI
Roadmap for America's Cancer Explorers for the 21st Century (Race 21)$331,637
R25 · FY2024 · CA
The UAB-ENhancing Research In Cancer-related Health professions (ENRICH) Program$324,000
R25 · FY2024 · CA · contact PI
Targeting actionable liabilities in Merlin-deficient breast cancer$173,559
R21 · FY2024 · CA · contact PI
Cancer Research Training and Education Coordination$155,928
P30 · FY2024 · CA · contact PI
Role of O-GlcNAc-ylation on tumor progression$154,171
R01 · FY2024 · CA · contact PI
Roadmap for America's Cancer Explorers for the 21st Century (Race 21)$417,910
R25 · FY2023 · CA
Role of O-GlcNAc-ylation on tumor progression$332,900
R01 · FY2023 · CA · contact PI
The UAB-ENhancing Research In Cancer-related Health professions (ENRICH) Program$324,000
R25 · FY2023 · CA · contact PI
Cancer Research Training and Education Coordination$155,925
P30 · FY2023 · CA · contact PI
Roadmap for America's Cancer Explorers for the 21st Century (Race 21)$417,910
R25 · FY2022 · CA
Role of O-GlcNAc-ylation on tumor progression$339,694
R01 · FY2022 · CA · contact PI
Cancer Research Training and Education Coordination$155,925
P30 · FY2022 · CA · contact PI
Roadmap for America's Cancer Explorers for the 21st Century (Race 21)$417,910
R25 · FY2021 · CA
Roadmap for America's Cancer Explorers for the 21st Century (Race 21)$417,910
R25 · FY2020 · CA
Mechanisms of resistance to cancer therapeutics$305,025
R01 · FY2018 · CA · contact PI
Mechanisms of resistance to cancer therapeutics$305,025
R01 · FY2017 · CA · contact PI
Mechanisms of resistance to cancer therapeutics$305,025
R01 · FY2016 · CA · contact PI
Molecular determinants of breast cancer malignancy$305,025
R01 · FY2015 · CA · contact PI
Mechanisms of resistance to cancer therapeutics$305,025
R01 · FY2015 · CA · contact PI
Mechanisms of resistance to cancer therapeutics$305,025
R01 · FY2014 · CA · contact PI
Molecular determinants of breast cancer malignancy$295,874
R01 · FY2014 · CA · contact PI
Molecular determinants of breast cancer malignancy$407,236
R01 · FY2013 · CA · contact PI
Molecular determinants of breast cancer malignancy$308,138
R01 · FY2012 · CA · contact PI
Molecular determinants of breast cancer malignancy$308,138
R01 · FY2011 · CA · contact PI